Fate Therapeutics (FATE) PT Lowered to $71 at Piper Sandler
Tweet
Share
E-mailGet Alerts FATE Hot Sheet
Price: $2.33 -4.9%
Rating Summary:
11 Buy, 13 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Rating Summary:
11 Buy, 13 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Join SI Premium – FREE
Piper Sandler analyst Edward A. Tenthoff lowered the price target on Fate Therapeutics (NASDAQ: FATE) to $71.00 (from $113.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Stella International Holdings (1836:HK) (SLNLF) PT Lowered to HK$10 at Macquarie
- Cummins (CMI) PT Lowered to $675 at Jefferies
- Beike (BEKE) PT Raised to $23 at Morgan Stanley
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
